CALCA and medullary thyroid gland carcinoma: This positions our study as the first to directly compare stimulating tests using two different agents, both containing calcium as the active component, in a patient population for whom such testing is most relevant—those with moderately elevated basal calcitonin levels (10–100 pg/mL) and sporadic MTC.